“Medically unexplained” symptoms and symptom disorders in primary care: prognosis-based recognition and classification by Rosendal, M. et al.
DEBATE Open Access
“Medically unexplained” symptoms and
symptom disorders in primary care:
prognosis-based recognition and
classification
Marianne Rosendal1,2* , Tim C Olde Hartman3, Aase Aamland4, Henriette van der Horst5, Peter Lucassen3,
Anna Budtz-Lilly1 and Christopher Burton6
Abstract
Background: Many patients consult their GP because they experience bodily symptoms. In a substantial proportion of
cases, the clinical picture does not meet the existing diagnostic criteria for diseases or disorders. This may be because
symptoms are recent and evolving or because symptoms are persistent but, either by their character or the negative
results of clinical investigation cannot be attributed to disease: so-called “medically unexplained symptoms” (MUS).
MUS are inconsistently recognised, diagnosed and managed in primary care. The specialist classification systems
for MUS pose several problems in a primary care setting. The systems generally require great certainty about
presence or absence of physical disease, they tend to be mind-body dualistic, and they view symptoms from a
narrow specialty determined perspective. We need a new classification of MUS in primary care; a classification
that better supports clinical decision-making, creates clearer communication and provides scientific underpinning
of research to ensure effective interventions.
Discussion: We propose a classification of symptoms that places greater emphasis on prognostic factors.
Prognosis-based classification aims to categorise the patient’s risk of ongoing symptoms, complications, increased
healthcare use or disability because of the symptoms. Current evidence suggests several factors which may be
used: symptom characteristics such as: number, multi-system pattern, frequency, severity. Other factors are:
concurrent mental disorders, psychological features and demographic data. We discuss how these characteristics may
be used to classify symptoms into three groups: self-limiting symptoms, recurrent and persistent symptoms, and
symptom disorders. The middle group is especially relevant in primary care; as these patients generally have reduced
quality of life but often go unrecognised and are at risk of iatrogenic harm. The presented characteristics do not
contain immediately obvious cut-points, and the assessment of prognosis depends on a combination of several factors.
Conclusion: Three criteria (multiple symptoms, multiple systems, multiple times) may support the classification into
good, intermediate and poor prognosis when dealing with symptoms in primary care. The proposed new classification
specifically targets the patient population in primary care and may provide a rational framework for decision-making in
clinical practice and for epidemiologic and clinical research of symptoms.
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Background
Many patients consult their general practitioner (GP)
because they experience bodily symptoms. Western
medicine prioritises the assessment of symptoms to
diagnose disease, but symptoms are not exclusively
signs of disease [1]. Some symptoms represent ordinary
bodily sensations causing minor concern [2, 3], others
arise, or persist, due to processes which do not depend
on underlying disease [4]. When symptoms persist but,
either by their character or the negative results of clin-
ical investigation, cannot be attributed to disease, they
are commonly described as “medically unexplained
symptoms” (MUS).
Understanding, recognising, explaining and managing
MUS are core tasks in general practice. Nevertheless,
many practitioners are challenged by these tasks [5], not
least because conceptualisations of the problem are
unclear and vary between doctors [6–8]. Professional
assessment, communication and treatment are based
on knowledge of disease patterns and such patterns
may be described by classification criteria. This know-
ledge is also a precondition for communication with
patients in order to provide a reliable basis for their
subsequent actions. Furthermore, research in this field
is hampered by inconsistent criteria and would profit
considerably if we can reach consensus on a classifica-
tion which is useful in primary care [8].
This debate paper aims to describe why classification of
MUS in primary care is difficult - but important - and pro-
poses a shift in focus towards prognostic classification.
What causes MUS, if not disease?
Bodily symptoms arise from both peripheral and central
processes [4]. While disease-based medicine has focused
on peripheral triggers (i.e., disease or injury in an organ),
recent work has demonstrated the importance of central
symptom processing [9, 10]. “Central sensitisation” is an
example of central processes involved in the persistence
or amplification of symptoms. This was first elaborated
in relation to pain, but also appears to play a role for
other symptoms [9].
Symptom processing can be considered at the psycho-
logical level (as described in cognitive-behavioural
models of MUS [11]) and increasingly also at the neuro-
physiological level [12]. Furthermore, altered central
symptom processing may give rise to increased periph-
eral symptom production (e.g., autonomic arousal).
Previous models of MUS have emphasized the idea of
“somatisation”, i.e., the presence of bodily symptoms as
indirect markers of psychological distress [13]. Although
considerable comorbidity has been found between both
moderate and severe MUS and common mental disor-
ders, the idea of direct psychological causality to
symptoms is regarded too simplistic to account for
most MUS [14].
In this paper we will use the term MUS to refer to
symptoms which are primarily influenced by central pro-
cesses rather than peripheral organ disease or injury.
Some clinicians and researchers use the term “functional
symptoms” instead of MUS, but this is still used dispara-
gingly by some doctors and is probably not yet suitable
for widespread use in primary care settings. Additionally,
most medical specialties have clusters of MUS within
so-called ‘functional syndromes’ (e.g., Fibromyalgia, Irrit-
able Bowel Syndrome) [15]. We recognise that there is
no single ideal term here and patients prefer either spe-
cific syndrome labels (such as Fibromyalgia) or generic
terms including the word ‘physical’ as e.g., persistent
physical symptoms [16, 17]; however most primary care
physicians and researchers are familiar with the umbrella
term MUS and so we will continue to use it for now.
MUS in primary care
One in three consultations in primary care is concluded
without specific diagnosis [18] and approximately one in
six primary care consultations involve MUS [19, 20].
Yet, most patients consulting with MUS do so only spor-
adically. Around 3–10% of adult GP consulters have per-
sistent or recurring MUS [21–24]. This is associated
with reduced health-related quality of life, increased
healthcare use and increased prevalence of depression
and anxiety [24–26]. Furthermore, patients with MUS
have increased risk of drop-out from the labour market
[27].
There is good evidence that patients with MUS do not
get sustained reassurance from negative diagnostic tests
or medical opinions [28]. Despite this, both patients and
doctors may be trapped in a situation where they seek to
use a biomedical disease model in their search for cause
and explanations [29] because the alternatives involve
conflicts of real and perceived beliefs about the nature of
MUS. Consequently, MUS challenge both the GP and
the doctor-patient relationship [5, 30]; and many doctors
have negative attitudes towards patients with severe
MUS [31, 32]. Furthermore, patients with persistent
symptoms are at risk of iatrogenic harm as they may go
through numerous investigations and receive unneces-
sary treatment such as medication and surgery [33–35].
Finally, patients with MUS are generally less satisfied
with their encounters than patients with biomedical dis-
eases [36, 37] and may even feel rejected by their GP
[38, 39].
Why do we need to classify MUS in primary care?
Classification of MUS in primary care is needed for
three reasons: for explanations to patients, for clinical
decision-making and for research.
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For patients, the desire to make sense of symptoms
has been demonstrated repeatedly in studies of patients
with MUS [40–43]. Classification can act as a starting
point for an explanation which may lead to treatment or
support for self-management [44].
For professionals and health services, classifications as-
sist the clinical decisions on management, in particular
whether or not to pursue (further) clinical investigation.
Additionally, classification provides a shared language
for communication between professionals.
In research, consensus on classification provides con-
sistent entry criteria for epidemiological studies and clin-
ical trials; these are necessary to explore illness course
and to assess the effectiveness of interventions.
Why is classifying MUS so difficult in primary care?
From our experience with research and teaching of GPs,
we recognise three major problems relating to classifica-
tion of MUS in primary care: high clinical uncertainty,
mind-body dualism and the position of primary care be-
tween different perspectives on classification of MUS.
Primary care is a field of high clinical uncertainty
Primary care medicine is at the front line of the healthcare
system and consequently faces a high degree of uncertainty
when symptoms are first presented. This uncertainty may
arise from several sources: many patients with MUS also
develop (or already have) “explained” conditions, primary
care clinicians often see patients before conditions or symp-
tom patterns have fully developed, which makes it difficult
to exclude organic disease, and the generalists in primary
care are aware that they have less knowledge of uncommon
medical conditions than medical specialists.
All of these sources of uncertainty imply that GPs tend
to be cautious about firmly classifying patients as having
MUS [7, 23]. Therefore, any classification system for
MUS needs to be sufficiently flexible to accommodate
the fact that some (not most) patients with suspected
MUS will turn out to have underlying disease [45]. In
other words, classifications and recommendations for
general practice must allow GPs to “ride two horses”
from the first meeting with the patient to ensure that
both pathological and “medically unexplained” causes
for symptoms are considered in parallel.
Most doctors learned classifications which locate the
problem in the body or the mind, not both.
Medicine has a long tradition of mind-body dualism,
which is no longer tenable in the light of current think-
ing and knowledge about the integrated nature of brain
and body [46]. On the one hand, medical training and
the legal system both put major emphasis on the import-
ance of preventing delayed diagnosis of biomedical dis-
eases, so emphasising the biological aspect. On the other
hand, general practice has been heavily influenced by
psychological perspectives through writers like Balint
[47] who emphasise psycho-social causes of illness. Al-
though approaches such as the bio-psycho-social model
[1] seek to unite the mind and body in relation to illness,
in clinical practice this remains problematic.
GPs are taught to look for reasons that go beyond the
symptom: Why this? Why now? As we answer these
questions, psychosocial factors come into view. Psycho-
logical factors can almost always be found if we look
hard enough; they may be the true causes for symptoms,
as predisposing and/or triggering factors, or they may be
incidental. As diagnosticians, we learn to value the sim-
plest formulation (whether it be biological or psycho-
social). So, while patients with MUS recognise the role
of multiple factors in their symptoms [48, 49], the GP’s
instinct for simple formulations might imply that s/he
misses the opportunity to integrate identified compo-
nents in a way that is acceptable to the patients [50].
Primary care sits between different perspectives on
diagnosis of MUS
The third reason why classification of MUS in primary
care is difficult comes from the tension between two
very different perspectives on classification: within indi-
vidual medical specialties and from psychiatric epidemi-
ology. The single medical specialty perspective pays
most attention to specific symptom characteristics
within one organ system. Thus, it pays less attention to
symptoms in other bodily systems or to psychological
characteristics. An example of a single speciality classifi-
cation is the Rome Diagnostic Criteria for Functional
Gastrointestinal Disorders (a common type of MUS); it
specifies symptom characteristics and duration, but it
does so only in relation to the gastro-intestinal tract
[51]. On the other hand, psychiatric classifications pay
less attention to the characteristics of specific symptoms,
and most attention to the overall pattern of symptoms.
Such classifications include number of symptoms (total
or “unexplained”), presence of psychological criteria
(e.g., excessive distress) or stipulated level of healthcare
use. They continue to be challenged [52, 53].
GPs deal with both the narrow perspective of the
current (reason for encounter) symptoms and the wider
perspective of the whole patient. For example, a woman
with abdominal pain and bloating may have both typical
features of irritable bowel syndrome (IBS) and also add-
itional symptoms such as tiredness, concentration diffi-
culties and dizziness, which render her unable to work.
The following vignette illustrates a typical clinical case:
Anna is a 38-year-old office worker. She consults her
GP for the third time in two months about abdominal
pain and bloating, which are both worse after meals
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and have been present for several months. Similar
symptoms occurred a year ago for around four months,
but then disappeared for some months. She has no
“red flags” for serious disease, and the routine blood
tests (including antibodies for coeliac disease and
lactose intolerance) are normal. She has stopped going
out for meals with friends because of her symptoms.
She also experiences dizziness (without vertigo), fatigue
and difficulty concentrating. She has been unable to
go to work for the last three weeks because of her
symptoms. She describes her current symptoms as
being “always in the back of her mind”, even on days
when she is feeling better.
In the last three years, she has consulted her GP with
palpitations (a 24-hour ECG showed sinus tachycardia)
and pelvic pain. She has occasional migraine and more
frequent milder tension-type headaches, which occur
two or three days per week at work. Nevertheless, she
“keeps going” and bringing up her young family with
her husband, who works as an engineer in a factory
which is currently under threat of closure.
If seen by a gastroenterologist, Anna has IBS. If seen
by a psychiatrist, she has somatic symptom disorder
(SSD). If seen by a GP, she may have both and yet may
be diagnosed with neither, and the GP may wonder if
she needs more medical tests or a referral for psycho-
logical support. General practice thus sits in a “zone of
generalism” between the medical specialty classification
focusing on the nature of symptoms within a single
organ system and the psychiatric classification focusing
on numbers of symptoms rather than their nature. This
zone of generalism is characterised by the uncertainty
that is inherent in primary care medicine, but also by
the uncertainty related to deciding which type of diag-
nostic classification is the most appropriate (or useful).
Discussion: moving from diagnosis to prognosis as a
basis for classification
We have so far argued that there is a need for classifica-
tion of MUS. We have also argued that the current diag-
nostic classification is problematic in several ways: the
inevitable residual uncertainty, the problems of cause-
related mind-body dualism, and the zone of generalism
positioned between medical specialties and psychiatry.
In the remainder of this article, we will propose a solu-
tion that draws on recent thinking about prognostic
classification.
A new prognosis-based classification
Classification of disease on the basis of prognosis does
not seek to state definitively whether a patient does or
does not have a condition. Rather, prognosis-based
classification aims to categorise the patient’s risk of on-
going symptoms, complications or increased healthcare
use because of the condition [54, 55]. An example comes
from type 2 diabetes where a prognosis-based classifica-
tion is less concerned with whether a patient meets the
arbitrary criteria for diabetes than whether the prognosis
or risk of future events is affected. Thus, two patients
may both have a blood glucose level just above the
threshold for diabetes. Yet, this may have different rele-
vance if one is an obese 33-year-old (for whom it is a
highly significant prognostic factor) and the other is an
88-year-old with dementia in a care home (for whom it
is irrelevant).
Similarly, prognosis-based classification of MUS in pri-
mary care should not just consider whether a given
symptom could be explained or unexplained, but rather
should assess whether the symptom is likely to persist,
recur or seriously impact the patient’s quality of life or
future healthcare use.
Introducing prognosis-based classification of MUS in
primary care does not exclude the use of functional syn-
drome labels (e.g., IBS, fibromyalgia), but rather serves
to supplement these labels. We believe that positively
categorising based on prognosis could help the GPs to
better recognise when to concentrate on explaining and
managing symptoms – as disorders of symptom process-
ing – rather than continue the search for an organic
diagnosis when all the pointers are in the opposite
direction.
In terms of classification of MUS in primary care, we
propose a classification with three prognostic categories.
These three categories are based on current evidence
about prognosis and the different needs for interventions
depending on illness severity as described below. We call
these categories: “Self-limiting symptoms”, “Recurrent or
persistent symptoms” and “Symptom disorder”.
Self-limiting symptoms
Patients belonging in the self-limiting symptoms category
have a good prognosis [56]. Their symptoms are relatively
infrequent and unobtrusive. They occasionally seek
healthcare for symptoms which appear not to be due to
disease, and consultations for symptoms are usually single
rather than repeated.
Symptom disorder
On the other hand, patients in the symptom disorder
category have a poor prognosis. They have multiple
symptoms with substantial symptom related disability
and healthcare use. They commonly meet the clinical
criteria for psychiatric classification disorders, such as
SSD [57], or the research criteria for bodily distress syn-
drome (BDS) [58, 59]. Additionally, they may also have
comorbid emotional disorders [26]. For these relatively
Rosendal et al. BMC Family Practice  (2017) 18:18 Page 4 of 9
few patients, we recommend that GPs consider using
specific diagnoses in accordance with the criteria for
psychiatric disorders and functional syndromes.
Recurrent or persistent symptoms
This leaves a prognostic category between these two ex-
tremes which we term “recurrent or persistent symp-
toms”. Patients in this middle category have repeated
(although not necessarily frequent) symptoms for which
they consult. These symptoms tend to persist for longer
than patient or physician would expect, they are associ-
ated with reduced quality of life, and they may include a
mix of unexplained and explained conditions. Patients
with “recurrent or persistent symptoms” are much more
common than patients with poor prognosis, but they
often go unrecognised in primary care as they are mis-
taken for having (yet undetected) physical disease [45].
The reasons for this are not fully clear, but it may be
because GPs lack a commonly used classification term
for this group as they reserve MUS labels for patients
in the more severe “symptom disorder” category. Con-
sequently, we do not communicate about these patients
as an independent group in need of specific manage-
ment [7]. Our choice of label includes “persistent symp-
toms” because this term has been found more
acceptable to patients than other labels for functional
symptoms or syndromes [16].
What information is needed for prognostic classification?
The prognosis for the patient – whether the symptoms
will resolve, persist or increase (in time, scope, severity
or impact) – can be influenced by a range of factors. We
will here focus on the factors that can be readily elicited
in a GP consultation or from primary care records and
we present them grouped in themes.
Symptom characteristics
Number of symptoms
Prospective studies have repeatedly demonstrated the
value of “number of symptoms” as a predictor of poor
health status in long-term follow-up studies [60–62].
This is true for symptoms in general, for MUS [63] and
for somatoform disorders [64].
In the case of musculoskeletal pain, the number of
pain-affected bodily sites is also a predictor of poor out-
come in terms of disability [65, 66]. Finally, number of
symptoms and number of pain sites have been shown to
predict work disability [27, 67, 68].
Multi-system patterns of symptoms
Earlier studies widely used the total number of symp-
toms, whereas recent work has pointed to the value of
including patterns of symptoms in multiple body sys-
tems. This is consistent with research demonstrating
large overlaps between symptoms of different functional
syndromes in severe conditions [69, 70]. Recent studies
on BDS suggest that central sensitisation not only results
in multiple symptoms; it may also prompt several spe-
cific symptom patterns described by arousal and/or ex-
haustion symptoms [58, 59, 70]. These symptoms cluster
in four groups: 1) cardiopulmonary/autonomic arousal
symptoms (palpitations/heart pounding, precordial dis-
comfort, breathlessness without exertion, hyperventila-
tion, hot or cold sweats, dry mouth), 2) gastrointestinal
arousal symptoms (abdominal pains, frequent loose
bowel movements, feeling bloated/full of gas/distended,
regurgitations, diarrhoea, nausea, burning sensation in
chest or epigastrium), 3) musculoskeletal tension symp-
toms (pains in arms or legs, muscular aches or pains,
pains in the joints, feelings of paresis or localized weak-
ness, backache, pain moving from one place to another,
unpleasant numbness or tingling sensations), and 4) gen-
eral symptoms (concentration difficulties, impairment of
memory, excessive fatigue, headache, dizziness).
Patients with BDS have a high risk of poor quality of life,
medicalisation and long-term persistence [25, 68, 71].
Interestingly, one study on MUS also found autonomic
sensations to be an indicator of poor outcome [72].
Hence, symptom patterns of central sensitization as
for example those seen in BDS may be a way forward to
identify the most severely affected group of patients with
symptom disorders [73].
Duration and frequency of symptoms
Duration and frequency of symptoms are included in
certain specialist classifications (e.g., the Rome Diagnos-
tic Criteria for Functional Gastrointestinal Disorders
[51]), but the value of this is less clear in primary care
and few intervention studies present data on the dur-
ation of symptoms at patient inclusion [63]. Failure of
symptoms to resolve within three months has been
found to be predictive of long-term persistence [74].
Many patients with MUS present intermittent symptoms
and repeated episodes over one year [22] or occasional epi-
sodes warranting referrals over several years [75].
Severity of symptoms
High symptom severity and baseline disability, or the
seriousness of the condition at baseline, seem to influ-
ence the prognosis. This has been found both in studies
of pain and in patients with MUS [63, 65, 66].
Disability is already a central feature in the diagnostic
criteria for disorders representing a spectrum of severity,
e.g., psychiatric diagnoses such as depression and anxiety
disorders [76]. As symptoms in themselves represent a
spectrum of severity, the degree of disability may serve
as a delimitation criterion to help distinguish between
less severe and more severe conditions.
Rosendal et al. BMC Family Practice  (2017) 18:18 Page 5 of 9
Personal characteristics
Concurrent disorders
The prognostic value of common mental disorders is
weak in patients presenting recent onset symptoms in
primary care [63]. In patients with multiple symptoms
categorised with either “recurrent or persistent symp-
toms” or “symptom disorders”, the presence of anxiety
and/or depression is associated with future persistence
of symptoms [62, 64]. This association also holds for co-
existing physical disease [62].
Psychological factors
Psychological factors also play a role as risk indicators. Ill-
ness worry may be an important factor [61, 74, 77] along
with more general aspects of negative illness perceptions
[78], negative affect, causal attributions [72] and maladap-
tive coping, e.g., fear avoidance and catastrophizing [72,
79]. Finally, negative life events [72] and reported abuse
during childhood predict poor outcome [62].
Demographic factors
Besides symptom and health characteristics, a few demo-
graphic factors have been investigated. Older age is a
predictor of poor outcome in general [62, 64, 65]. Low
education level and unmarried status (separated,
widowed or divorced) indicate risk of symptom persist-
ence in patients with high symptom scores [62].
From prognostic information to classification
The factors described above do not contain natural or
intuitive cut-points. Therefore, any assessment of prog-
nosis will depend on a combination of several factors.
We have selected three of the presented factors that
merit particular emphasis: number of symptoms, num-
ber of bodily system and frequency of symptoms in the
patient. These can be summarised as “multiple symp-
toms, multiple systems and multiple times”.
We propose to direct special attention to these three
symptom factors for several reasons: (a) our experience
with training GPs suggests that these factors are not
routinely recognised in general practice despite their
prominence in the research literature; (b) severity, con-
current disorders and demographic factors are prognos-
tic factors for almost all conditions and not specifically
to MUS; (c) assessment of psychological factors is a
challenge in primary care because it requires special
knowledge, skills and time, which may not be within
easy reach in general practice. GPs tend to have a biased
focus with a strong preference for biomedicine in their
clinical assessment [80], and the recognition of these
symptom characteristics is concordant with this mode of
thinking. In Table 1, we provide qualitative descriptions
of the way that patients may be classified using these
three criteria.
Of the three categories in our prognostic classification,
the second category “recurrent or persistent symptoms”
is key for primary care. Although self-limiting symptoms
are common, their good prognosis means that they can
safely be managed within conventional consultations.
Symptom disorder affects relatively few patients; most of
these patients meet the criteria for psychiatric classifica-
tion disorders, such as SSD, of at least moderate severity,
and they may benefit from specialist or multidisciplinary
treatment. Identifying patients with “recurrent or persist-
ent symptoms” using criteria of multiple symptoms,
multiple systems and multiple times has six potential
advantages: (i) patients with increased likelihood of
continuing or future symptoms are quickly identified,
(ii) by emphasising patterns of symptoms rather than
their nature, the category is easier to use in consulta-
tions where patients are struggling to have the severity
of their symptoms heard [81], (iii) it implies a common
problem with symptom processing [9] rather than dir-
ect causes for individual symptoms and so may shift
the focus of diagnostic attention away from peripheral
causes, (iv) the new approach does not exclude periph-
eral causes and can be used in parallel with further
diagnostic assessment as indicated by new symptoms,
(v) the new approach opens the door to “rational expla-
nations” [44] and embraces both peripheral and central
Table 1 Proposed qualitative prognostic classification of symptoms based on “multiple symptoms, multiple systems and multiple times”
Self-limiting symptoms Recurrent or persistent symptoms a Symptom disorder
Number of symptoms +
Few and related symptoms
++
Several symptoms
(at same time or on different occasions)
+++
Many symptoms concurrently
and/or over time
Number of body systems b +
One body system
++
One or more body systems
+++
Several body systems
Number of times +
Few/infrequent
++
Several - intermittent or low-level persistence
+++
Many times or continuously
Risk of poor outcome Low Medium High
a Both “Recurrent or Persistent Symptoms” and “Symptom Disorder” meet the three criteria “multiple symptoms, multiple systems, multiple times”; they vary in
the extent to which these criteria are met
b For research, rigid criteria may apply; for clinical practice (as the aim is prognosis rather than formal diagnosis), “number of body systems” is applied more
flexibly, e.g., grouping of symptoms by digestive, cardiovascular, genitourinary, etc., systems
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processes as causes of symptoms, and, finally, (vi) once
more clearly defined, the criteria are sufficiently simple
to use in both observational and interventional clinical
research and yet may also serve as a diagnostic tool in
daily clinical practice.
Next steps
We believe that the suggested classification could be used
in routine care. Taking a prognostic approach, while
remaining agnostic about aetiology, is likely to be accept-
able for both doctors and patients. However, the imple-
mentation of a new classification approach will need
investigations on its own in primary care populations.
The prognostic classification also highlights the need
for primary care research to develop and evaluate ap-
propriate management interventions for patients with
recurring or persistent symptoms. Such interventions
need to integrate both the biological dimension and the
psychosocial dimension and are likely to include en-
hanced explanation and symptom management tech-
niques while maintaining an eye on the horizon for
hitherto unrecognised disease. The success, or other-
wise, of a prognostic classification in primary care may
depend on what happens elsewhere in health services.
While open discussion with patients about prognostic
categorisation may help limit testing and referral in
healthcare systems where primary care has a strong
gatekeeper function, it may need adoption across other
specialties where patients are able to directly access
multiple specialist opinions.
Conclusion
Classification of symptoms into rigid categories of organic
or medically unexplained is neither feasible nor helpful in
primary care. Such classification may rather imply that
symptoms are difficult to operationalize, investigate and
manage. In this paper, we propose a new approach to clas-
sification of symptoms that places greater emphasis on
prognostic factors. We argue that three specific criteria
(multiple symptoms, multiple systems, multiple times)
can act as simple classifiers into categories of good, inter-
mediate and poor prognosis. This new classification may
provide a rational framework for both clinical practice and
future research.
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